11-89007211-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001143831.3(GRM5):c.661+40001T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.792 in 152,154 control chromosomes in the GnomAD database, including 48,564 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.79 ( 48564 hom., cov: 33)
Consequence
GRM5
NM_001143831.3 intron
NM_001143831.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.953
Publications
11 publications found
Genes affected
GRM5 (HGNC:4597): (glutamate metabotropic receptor 5) This gene encodes a member of the G-protein coupled receptor 3 protein family. The encoded protein is a metabatropic glutamate receptor, whose signaling activates a phosphatidylinositol-calcium second messenger system. This protein may be involved in the regulation of neural network activity and synaptic plasticity. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. A pseudogene of this gene has been defined on chromosome 11. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.94 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRM5 | NM_001143831.3 | c.661+40001T>C | intron_variant | Intron 2 of 9 | ENST00000305447.5 | NP_001137303.1 | ||
GRM5 | NM_000842.5 | c.661+40001T>C | intron_variant | Intron 2 of 8 | NP_000833.1 | |||
GRM5 | NM_001384268.1 | c.661+40001T>C | intron_variant | Intron 2 of 8 | NP_001371197.1 | |||
GRM5 | XM_011542792.2 | c.661+40001T>C | intron_variant | Intron 2 of 9 | XP_011541094.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.792 AC: 120418AN: 152036Hom.: 48500 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
120418
AN:
152036
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.792 AC: 120538AN: 152154Hom.: 48564 Cov.: 33 AF XY: 0.793 AC XY: 58950AN XY: 74378 show subpopulations
GnomAD4 genome
AF:
AC:
120538
AN:
152154
Hom.:
Cov.:
33
AF XY:
AC XY:
58950
AN XY:
74378
show subpopulations
African (AFR)
AF:
AC:
39340
AN:
41524
American (AMR)
AF:
AC:
11994
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
2451
AN:
3472
East Asian (EAS)
AF:
AC:
3759
AN:
5174
South Asian (SAS)
AF:
AC:
4277
AN:
4824
European-Finnish (FIN)
AF:
AC:
7375
AN:
10558
Middle Eastern (MID)
AF:
AC:
229
AN:
294
European-Non Finnish (NFE)
AF:
AC:
48662
AN:
67980
Other (OTH)
AF:
AC:
1671
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1228
2457
3685
4914
6142
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2937
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.